[1]
|
Mostert, J.P., Koch, M.W., Steen, C., Heersema, D.J., De Groot, J.C. and De Keyser, J. (2010) T2 lesions and rate of progression of disability in multiple sclerosis. European Journal of Neurology, 17, 1471-1475.
doi:10.1111/j.1468-1331.2010.03093.x
|
[2]
|
Pelletier, J., Audoin, B., Reuter, F. and Ranjeva, J. (2009) Plasticity in MS: From functional imaging to rehabilitation. The International MS Journal, 16, 26-31.
|
[3]
|
Zivadinov, R. (2009) Advanced magnetic resonance imaging metrics: Implications for multiple sclerosis clinical trials. Methods and Findings in Experimental and Clinical Pharmacology, 31, 29-40.
doi:10.1358/mf.2009.31.1.1346612
|
[4]
|
Strasser-Fuchs, S., Enzinger, C., Ropele, S., Wallner, M. and Fazekas, F. (2008) Clinically benign multiple sclerosis despite large T2 lesion load: Can we explain this paradox? Multiple Sclerosis Journal, 14, 205-211.
doi:10.1177/1352458507082354
|
[5]
|
Barkhof, F. (2002) The clinico-radiological paradox in multiple sclerosis revisited. Current Opinion in Neurology, 15, 239-245.
doi:10.1097/00019052-200206000-00003
|
[6]
|
Polman, C.H., Reingold, S.C., Banwell, B., Clanet, M., Cohen, J.A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., Lublin, F.D., Montalban, X., O’Connor, P., Sandberg-Wollheim, M., Thompson, A.J., Waubant, E., Weinshenker, B. and Wolinsky, J.S. (2011) Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Annals of Neurology, 69, 292-302. doi:10.1002/ana.22366
|
[7]
|
Paty, D.W., Oger, J.J., Kastrukoff, L.F., Hashimoto, S.A., Hooge, J.P., Eisen, A.A., et al. (1988) MRI in the diagnosis of MS: A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology, 38, 180-185.
doi:10.1212/WNL.38.2.180
|
[8]
|
McDonald, W.I., Compston, A., Edan, G., Goodkin, D., Hartung, H.P., Lublin, F.D., McFarland, H.F., Paty, D.W., Polman, C.H., Reingold, S.C., Sandberg-Wollheim, M., Sibley, W., Thompson, A., van den Noort, S., Weinshenker, B.Y. and Wolinsky, J.S. (2001) Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Annals of Neurology, 50, 121-127.
doi:10.1002/ana.1032
|
[9]
|
Van Walderveen, M.A.A., Barkhof, F., Hommes, O.R., Polman, C.H., Tobi, H., Frequin, S.T.F.M., et al. (1995) Correlating MRI and clinical disease activity in multiple sclerosis: Relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images. Neurology, 45, 1684-1690. doi:10.1212/WNL.45.9.1684
|
[10]
|
Kurtzke, J.F. (1983) Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology (Cleveland), 33, 1444-1452.
doi:10.1212/WNL.33.11.1444
|
[11]
|
Pike, G.B., De Stefano, N., Narayanan, S., et al. (1999) Combined magnetization transfer and proton spectroscopic imaging in the assessment of pathologic brain lesions in multiple sclerosis. American Journal of Neuroradiology, 20, 829-837.
|
[12]
|
Filippi, M., McGowan, J.C. and Tortorella, C. (2007) Measures of magnetization transfer in multiple sclerosis. In: Cohen, J.A. and Rudick, R.A., Eds. Multiple Sclerosis Therapeutics, 3rd Edition, Informa Healthcare, London, 143-144, 171.
|
[13]
|
Carlos Santos, A., Narayanan, S., De Stefano, N., et al. (2000) Magnetization transfer can predict clinical evolution in patients with multiple sclerosis. Journal of Neurology, 249, 662-668. doi:10.1007/s00415-002-0686-4
|
[14]
|
Fox, R.J. (2008) Picturing multiple sclerosis: Conventional and diffusion tensor imaging. Seminars in Neurology, 28, 453-466. doi:10.1055/s-0028-1083689
|
[15]
|
Vrenken, H., Pouwels, P.J.W., Geurts, J.J.G., et al. (2006) Altered diffusion in multiple sclerosis normal appearing brain tissue: Cortical diffusion changes seem related to clinical deterioration. Journal of Magnetic Resonance Imaging, 23, 628-636. doi:10.1002/jmri.20564
|
[16]
|
Audoin, B., Maxime, G., Reuter, F., et al. (2007) Structure of WM bundles constituting the working memory system in early multiple sclerosis: A quantitative DTI tractography study. NeuroImage, 36, 1324-1330.
doi:10.1016/j.neuroimage.2007.04.038
|
[17]
|
Fu, L., Matthews, P.M., De Stefano, N., et al. (1998) Imaging of axonal damage of normal appearing white matter in multiple sclerosis. Brain, 121, 103-113.
doi:10.1093/brain/121.1.103
|
[18]
|
Mathews, P.M., Francis, G., Antel, J. and Arnold, D.L. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology, 41, 1521-1526. doi:10.1212/WNL.41.8.1251
|
[19]
|
Chard, D.T., Griffin, C.M., McLean, M.A., et al. (2002) Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain, 125, 2342-2352.
doi:10.1093/brain/awf240
|
[20]
|
Rocca, M.A., Colombo, B., Falini, A., Ghezzi, A., Martinelli, V., Scotti, G., et al. (2005) Cortical adaptation in patients with MS: A cross-sectional functional MRI study of disease phenotypes. The Lancet Neurology, 4, 618-626.
doi:10.1016/S1474-4422(05)70171-X
|
[21]
|
Mainero, C., Pantano, P., Caramia, F. and Pozzilli, C. (2006) Brain reorganization during attention and memory tasks in multiple sclerosis: Insights from functional MRI studies. Journal of the Neurological Sciences, 245, 93-98.
doi:10.1016/j.jns.2005.08.024
|